Importer of Controlled Substances Application: Noramco, 77108 [2023-24614]
Download as PDF
<![CDATA[
77108
Federal Register / Vol. 88, No. 215 / Wednesday, November 8, 2023 / Notices
Sunshine Act, 5 U.S.C. 552(b). In
accordance with Commission policy,
subject matter listed above, not disposed
of at the scheduled meeting, may be
carried over to the agenda of the
following meeting.
By order of the Commission.
Issued: November 6, 2023.
Sharon Bellamy,
Supervisory Hearings and Information
Officer.
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on October 4, 2023,
Noramco, 500 Swedes Landing Road,
Wilmington, Delaware 19801–4417,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
[FR Doc. 2023–24812 Filed 11–6–23; 11:15 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Controlled
substance
Drug Enforcement Administration
[Docket No. DEA–1287]
Importer of Controlled Substances
Application: Noramco
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Noramco has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before December 8, 2023. Such
persons may also file a written request
for a hearing on the application on or
before December 8, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
lotter on DSK11XQN23PROD with NOTICES1
DATES:
VerDate Sep<11>2014
16:54 Nov 07, 2023
Jkt 262001
Gamma Hydroxybutyric
Acid.
Marihuana .......................
Tetrahydrocannabinols ...
Nabilone .........................
Phenylacetone ................
Opium, Raw ....................
Opium Extracts ...............
Opium Fluid Extract ........
Opium Tincture ...............
Opium Powdered ............
Opium Granulated ..........
Opium Poppy/Poppy
Straw.
Noroxymorphone ............
Poppy Straw Concentrate.
Tapentadol ......................
Drug
code
Schedule
2010
I
7360
7370
7379
8501
9600
9610
9620
9630
9639
9640
9650
I
I
II
II
II
II
II
II
II
II
II
9668
9670
II
II
9780
II
The company plans to import
Phenylacetone (8501), and Poppy Straw
Concentrate (9670) to bulk manufacture
other controlled substances for
distribution to its customers. The
company plans to import an
intermediate form of Tapentadol (9780)
to bulk manufacture Tapentadol for
distribution to its customers. In
reference to drug codes 7360
(Marihuana) and 7370
(Tetrahydrocannabinols), the company
plans to import a synthetic cannabidiol
and a synthetic Tetrahydrocannabinol.
No other activity for these drug codes is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–24614 Filed 11–7–23; 8:45 am]
BILLING CODE P
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1286]
Bulk Manufacturer of Controlled
Substances Application: Noramco
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Noramco has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before January 8, 2024. Such
persons may also file a written request
for a hearing on the application on or
before January 8, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on October 04, 2023,
Noramco, 500 Swedes Landing Road,
Wilmington, Delaware 19801–4417,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUMMARY:
Controlled
substance
Gamma Hydroxybutyric
Acid.
Marihuana .......................
Tetrahydrocannabinols ...
Codeine-N-oxide .............
Dihydromorphine ............
Hydromorphinol ..............
Morphine-N-oxide ...........
Amphetamine .................
Lisdexamfetamine ..........
Methylphenidate .............
E:\FR\FM\08NON1.SGM
08NON1
Drug
code
Schedule
2010
I
7360
7370
9053
9145
9301
9307
1100
1205
1724
I
I
I
I
I
I
II
II
II
]]>Agencies
[Federal Register Volume 88, Number 215 (Wednesday, November 8, 2023)]
[Notices]
[Page 77108]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24614]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1287]
Importer of Controlled Substances Application: Noramco
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Noramco has applied to be registered as an importer of basic
class(es) of controlled substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
December 8, 2023. Such persons may also file a written request for a
hearing on the application on or before December 8, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on October 4, 2023, Noramco, 500 Swedes Landing Road,
Wilmington, Delaware 19801-4417, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.............. 2010 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
Nabilone............................... 7379 II
Phenylacetone.......................... 8501 II
Opium, Raw............................. 9600 II
Opium Extracts......................... 9610 II
Opium Fluid Extract.................... 9620 II
Opium Tincture......................... 9630 II
Opium Powdered......................... 9639 II
Opium Granulated....................... 9640 II
Opium Poppy/Poppy Straw................ 9650 II
Noroxymorphone......................... 9668 II
Poppy Straw Concentrate................ 9670 II
Tapentadol............................. 9780 II
------------------------------------------------------------------------
The company plans to import Phenylacetone (8501), and Poppy Straw
Concentrate (9670) to bulk manufacture other controlled substances for
distribution to its customers. The company plans to import an
intermediate form of Tapentadol (9780) to bulk manufacture Tapentadol
for distribution to its customers. In reference to drug codes 7360
(Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to
import a synthetic cannabidiol and a synthetic Tetrahydrocannabinol. No
other activity for these drug codes is authorized for this
registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-24614 Filed 11-7-23; 8:45 am]
BILLING CODE P
